IDD-BIOTECH-LOGOApril 19, 2016: iDD Biotech announces milestone achievement in DR5 antibody collaboration with Genmab

iDD biotech announces the achievement of the first milestone under the agreement signed one year ago with Genmab A/S, a publicly traded, international biotechnology company specializing in the creation and development of differentiated human antibody therapeutics for the treatment of cancer.

Read more